Misa Togi
Kahoku, 9200293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells.
Journal: Cancers
Published: May 27, 2023
The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion.
Journal: International journal of molecular sciences
Published: August 29, 2022
Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies.
Journal: International journal of molecular sciences
Published: June 04, 2022
Identification of CD56dim subpopulation marked with high expression of GZMB/PRF1/PI-9 in CD56+ interferon-α-induced dendritic cells.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: January 16, 2021
Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes.
Journal: Vaccines
Published: November 25, 2020
Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination.
Journal: Pharmaceutics
Published: January 31, 2020
In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.
Journal: Vaccines
Published: August 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026